Pyxis Oncology, Inc.

PYXS

Held by 2 specialist biotech funds

Share on X

Fund Holdings

Perceptive Advisors

Driehaus Capital

Position Trend

Nov 14, 2025

$3.5M

2 funds

Feb 17, 2026

$0

0 funds

-100% total institutional value over 2 quarters

Short Interest

Short Shares

2.49M

Change

+1.9%

Days to Cover

8.3

% of Float

4.8%

Settlement

Mar 13, 2026

Short interest over 2 periods

Catalysts

No catalysts tracked.

Activist Filings

SC 13G/ARA Capital Management0.0%Feb 14, 2023

SC 13G/ARA Capital Management7.0%Feb 14, 2022

SC 13GRA Capital Management5.8%Oct 25, 2021

Position Details

Perceptive AdvisorsEXITFeb 17, 2026

Shares: 1,178,307Value: $2.6M

Driehaus CapitalEXITFeb 17, 2026

Shares: 418,632Value: $929K

+ 2more — see how much conviction went in

See the Full Story

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

NBIX2 funds PTGX2 funds ANRO2 funds APGE2 funds AMLX2 funds BBNX2 funds BSX2 funds CELC2 funds

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: